The mission of the Cooperative Threat Reduction (CTR) program is to partner with willing countries to reduce threat from weapons of mass destruction (WMD) and related materials, technologies, facilities, and expertise. The [Read more]
The U.S. Army for Medical Research Institute of Infectious Diseases (USAMRIID) has suspended Biosafety Level 3 (BSL-3) and Biosafety Level 4 (BSL-4) operations while conducting repairs to its waste treatment plant. Unprecedented [Read more]
The 2018 review of the World Health Organization’s Blueprint list of priority diseases occurred February 6-7, 2018. Given their potential to cause a public health emergency and the absence of efficacious medical [Read more]
The U.S. Department of Agriculture’s (USDA) National Institute of Food and Agriculture (NIFA) has announced a competitive opportunity to conduct research on the environmental effects of genetically engineered (GE) organisms, including plants, [Read more]
In 2016, an estimated 90,000 people died from measles – an 84% drop from more than 550,000 deaths in 2000, according to the World Health Organization. From The Shadow Crusade to End [Read more]
Battelle has been awarded a contract by the Intelligence Advanced Research Projects Activity (IARPA) to develop threat assessment software to help prevent the creation of dangerous organisms. IARPA’s Functional Genomic and Computational Assessment [Read more]
Biosecurity professionals from across the U.S. and Mexico gathered on Arizona State University’s Tempe campus Dec. 7 and 8 to discuss multidisciplinary approaches and perspectives on biosecurity. The two-day Arizona Biosecurity Workshop [Read more]
The Intelligence Advanced Research Projects Activity (IARPA) this week announced a multi-year research effort to develop new biosecurity tools under the Functional Genomic and Computational Assessment of Threats (Fun GCAT) program. In [Read more]
It is imperative for medical experts and drug discovery specialists to stay on top of the latest clinical advancements, developments and industry initiatives related to antimicrobial resistance. SMi Group will gather industry experts [Read more]
The Biomedical Advanced Research and Development Authority (BARDA) has awarded funding to Tangen BioSciences for advanced development of the company’s rapid anthrax diagnostic. The $3,199,221 base period award was announced by BARDA [Read more]
© 2018 Global Biodefense